Supernus Pharmaceuticals Statistics
Total Valuation
SUPN has a market cap or net worth of $2.83 billion. The enterprise value is $2.60 billion.
Important Dates
The next estimated earnings date is Tuesday, February 24, 2026, after market close.
| Earnings Date | Feb 24, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SUPN has 57.34 million shares outstanding. The number of shares has increased by 0.54% in one year.
| Current Share Class | 57.34M |
| Shares Outstanding | 57.34M |
| Shares Change (YoY) | +0.54% |
| Shares Change (QoQ) | -0.16% |
| Owned by Insiders (%) | 4.32% |
| Owned by Institutions (%) | 102.19% |
| Float | 54.84M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 19.53 |
| PS Ratio | 4.07 |
| Forward PS | 3.37 |
| PB Ratio | 2.69 |
| P/TBV Ratio | 9.25 |
| P/FCF Ratio | 40.13 |
| P/OCF Ratio | 39.50 |
| PEG Ratio | 0.53 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 21.86, with an EV/FCF ratio of 36.76.
| EV / Earnings | n/a |
| EV / Sales | 3.82 |
| EV / EBITDA | 21.86 |
| EV / EBIT | 77.51 |
| EV / FCF | 36.76 |
Financial Position
The company has a current ratio of 1.80, with a Debt / Equity ratio of 0.04.
| Current Ratio | 1.80 |
| Quick Ratio | 1.37 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 0.32 |
| Debt / FCF | 0.60 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -1.86% and return on invested capital (ROIC) is 4.85%.
| Return on Equity (ROE) | -1.86% |
| Return on Assets (ROA) | 1.52% |
| Return on Invested Capital (ROIC) | 4.85% |
| Return on Capital Employed (ROCE) | 3.08% |
| Revenue Per Employee | $1.01M |
| Profits Per Employee | -$28,364 |
| Employee Count | 674 |
| Asset Turnover | 0.49 |
| Inventory Turnover | 1.06 |
Taxes
| Income Tax | -1.62M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +28.36% in the last 52 weeks. The beta is 0.68, so SUPN's price volatility has been lower than the market average.
| Beta (5Y) | 0.68 |
| 52-Week Price Change | +28.36% |
| 50-Day Moving Average | 47.98 |
| 200-Day Moving Average | 41.26 |
| Relative Strength Index (RSI) | 47.79 |
| Average Volume (20 Days) | 582,872 |
Short Selling Information
The latest short interest is 4.38 million, so 7.65% of the outstanding shares have been sold short.
| Short Interest | 4.38M |
| Short Previous Month | 4.81M |
| Short % of Shares Out | 7.65% |
| Short % of Float | 7.99% |
| Short Ratio (days to cover) | 7.13 |
Income Statement
In the last 12 months, SUPN had revenue of $681.54 million and -$19.12 million in losses. Loss per share was -$0.34.
| Revenue | 681.54M |
| Gross Profit | 605.63M |
| Operating Income | 33.55M |
| Pretax Income | -20.73M |
| Net Income | -19.12M |
| EBITDA | 118.94M |
| EBIT | 33.55M |
| Loss Per Share | -$0.34 |
Full Income StatementBalance Sheet
The company has $281.16 million in cash and $42.21 million in debt, with a net cash position of $238.95 million or $4.17 per share.
| Cash & Cash Equivalents | 281.16M |
| Total Debt | 42.21M |
| Net Cash | 238.95M |
| Net Cash Per Share | $4.17 |
| Equity (Book Value) | 1.05B |
| Book Value Per Share | 18.38 |
| Working Capital | 263.26M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $71.88 million and capital expenditures -$1.12 million, giving a free cash flow of $70.75 million.
| Operating Cash Flow | 71.88M |
| Capital Expenditures | -1.12M |
| Free Cash Flow | 70.75M |
| FCF Per Share | $1.23 |
Full Cash Flow StatementMargins
Gross margin is 88.86%, with operating and profit margins of 4.92% and -2.80%.
| Gross Margin | 88.86% |
| Operating Margin | 4.92% |
| Pretax Margin | -3.04% |
| Profit Margin | -2.80% |
| EBITDA Margin | 17.45% |
| EBIT Margin | 4.92% |
| FCF Margin | 10.38% |
Dividends & Yields
SUPN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.54% |
| Shareholder Yield | -0.54% |
| Earnings Yield | -0.67% |
| FCF Yield | 2.49% |
Analyst Forecast
The average price target for SUPN is $61.60, which is 24.65% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $61.60 |
| Price Target Difference | 24.65% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 13.02% |
| EPS Growth Forecast (5Y) | 33.07% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SUPN has an Altman Z-Score of 4.52 and a Piotroski F-Score of 4.
| Altman Z-Score | 4.52 |
| Piotroski F-Score | 4 |
